» Articles » PMID: 36387075

Detection of Asymptomatic Recurrence Following Curative Surgery Improves Survival in Patients with Gastric Cancer: A Systematic Review and Meta-analysis

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Nov 17
PMID 36387075
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To date, there is no evidence that intensive follow-up provides survival benefit in gastric cancer patients undergoing curative gastrectomy. The aim of this study is to investigate the efficacy of detection of asymptomatic recurrence using intensive surveillance strategy in long-term survival after curative gastric cancer surgery.

Methods: A systematic review of electronic databases including PubMed, Embase, Web of Science, the Cochrane Library and China National Knowledge Infrastructure, Clinical Trials Registry and Google Scholar was performed up to April 2022. The primary outcomes were survival outcomes: overall survival, recurrence-free survival and post-recurrence survival. The secondary endpoints were clinicopathological features, recurrence patterns and treatment after recurrence. The registration number of this protocol is PROSPERO CRD42022327370.

Results: A total of 11 studies including 1898 participants were included. In the pooled analysis, the detection of asymptomatic recurrence was significantly associated with an improved overall survival compared to patients showing symptoms of recurrence (HR=0.67; 95%CI: 0.57-0.79; P<0.001), which was primarily driven by the prolongation of post-recurrence survival (HR=0.51; 95%CI: 0.42-0.61; P<0.001), since there was no significant difference observed in recurrence-free survival (HR=1.12; 95%CI: 0.81-1.55; P=0.48) between the two groups. Meanwhile, male sex and advanced T stage were more frequently observed in the symptomatic recurrence group. Furthermore, patients in the symptomatic recurrence group had a higher proportion of peritoneal relapse but lower proportion of distant lymph node metastasis. Additionally, patients in the symptomatic recurrence group were less likely to receive surgery treatment and post-recurrence chemotherapy.

Conclusion: The detection of asymptomatic recurrence using intensive follow-up was associated with an appreciable improvement in overall survival. However, more robust data from high-quality studies are still required to verify this issue.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=327370, identifier CRD42022327370.

Citing Articles

Prognostic value of the pretreatment Naples prognostic score in patients with colorectal cancer: a systematic review and meta-analysis.

Liu H, Zhu D, Jiang D, Pang H, Yang X Front Oncol. 2025; 14():1498854.

PMID: 39839774 PMC: 11746047. DOI: 10.3389/fonc.2024.1498854.


Laparoscopic versus open gastrectomy for nonmetastatic T4a gastric cancer: a meta-analysis of reconstructed individual participant data from propensity score-matched studies.

Pang H, Yan M, Zhao Z, Chen L, Chen X, Chen Z World J Surg Oncol. 2024; 22(1):143.

PMID: 38812025 PMC: 11134691. DOI: 10.1186/s12957-024-03422-5.


Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis.

Sun K, Xu R, Rong H, Pang H, Xiang T Ann Med. 2023; 55(2):2236640.

PMID: 37851510 PMC: 10586078. DOI: 10.1080/07853890.2023.2236640.


Prognostic significance of the pretreatment pan-immune-inflammation value in cancer patients: an updated meta-analysis of 30 studies.

Hai-Jing Y, Shan R, Jie-Qiong X Front Nutr. 2023; 10:1259929.

PMID: 37850085 PMC: 10577316. DOI: 10.3389/fnut.2023.1259929.


Clinical significance of the advanced lung cancer inflammation index in gastrointestinal cancer patients: a systematic review and meta-analysis.

Pang H, Chen X, Yan M, Chen L, Chen Z, Zhang S Front Oncol. 2023; 13:1021672.

PMID: 37404758 PMC: 10316012. DOI: 10.3389/fonc.2023.1021672.


References
1.
. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2020; 24(1):1-21. PMC: 7790804. DOI: 10.1007/s10120-020-01042-y. View

2.
Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

3.
Ajani J, DAmico T, Bentrem D, Chao J, Cooke D, Corvera C . Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022; 20(2):167-192. DOI: 10.6004/jnccn.2022.0008. View

4.
Bilici A, Salman T, Ustaalioglu B, Unek T, Seker M, Aliustaoglu M . The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy. J Surg Res. 2012; 180(1):e1-9. DOI: 10.1016/j.jss.2012.03.035. View

5.
Pita-Fernandez S, Alhayek-Ai M, Gonzalez-Martin C, Lopez-Calvino B, Seoane-Pillado T, Pertega-Diaz S . Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol. 2014; 26(4):644-656. DOI: 10.1093/annonc/mdu543. View